2019
DOI: 10.1111/imj.14283
|View full text |Cite
|
Sign up to set email alerts
|

Non‐alcoholic fatty liver disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…NAFLD is an important metabolic syndrome, which, can increase mortality in obese and diabetic patients. 48 At present, the pathogenesis of NAFLD is complex, and is related to many factors, such as insulin resistance, oxidative stress, inflammatory mediators and cytokines. At present, there are no effective targeted drugs for the treatment of NAFLD, and treatment includes diet therapy and lifestyle adjustment, liver protection and lipid lowering, and insulin sensitization.…”
Section: Non-alcoholic Fatty Liver Diseasementioning
confidence: 99%
“…NAFLD is an important metabolic syndrome, which, can increase mortality in obese and diabetic patients. 48 At present, the pathogenesis of NAFLD is complex, and is related to many factors, such as insulin resistance, oxidative stress, inflammatory mediators and cytokines. At present, there are no effective targeted drugs for the treatment of NAFLD, and treatment includes diet therapy and lifestyle adjustment, liver protection and lipid lowering, and insulin sensitization.…”
Section: Non-alcoholic Fatty Liver Diseasementioning
confidence: 99%